VIVA

This channel contains news about the annual Vascular Interventional Advances (VIVA) conference. VIVA is a premier conference for new techniques and technologies to treat vascular disease. This includes the areas of peripheral artery disease (PAD), critical limb ischemia (CLI), endovascular repair and venous therapies. 

 

The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) were evaluated to determine if there is an increased mortality risk due to paclitaxel, but was no difference was seen in the five-year mortality rates compared to control patients. #VIVA19 #VIVA #VIVA2019
Feature | Stents Peripheral | Dave Fornell, Editor
No Increased Long-Term Mortality for the Paclitaxel-Coated Zilver PTX Stent

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

Home November 06, 2019
Home
The Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, #VIVA2019 #VIVA #VIVA19
News | Drug-Eluting Balloons
Safety and Efficacy Sustained Over Two Years in Selution Drug-eluting Balloon First-in-Human Trial

November 6, 2019 – Positive, two-year data from the first-in-human study of Selution SLR, MedAlliance’s novel sirolimus ...

Home November 06, 2019
Home
Eluvia and Ranger PAD devices from Boston Scientific. #VIVA19 #VIVA2019 #VIVA
News | Peripheral Artery Disease (PAD)
Positive Data for the Ranger Drug-coated Balloon and Eluvia Vascular Stent

November 6, 2019 – Boston Scientific announced positive data for two of its devices within the peripheral drug-eluting ...

Home November 06, 2019
Home
Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019
Feature | VIVA
VIVA 2019 Late-breaking Clinical Trials

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at Vascular ...

Home November 14, 2019
Home
News | Vena Cava Filters
One-Year SENTRY Data Presented at VIVA

September 26, 2017 — The one-year results of the SENTRY clinical trial were presented by principal investigator Michael ...

Home September 26, 2017
Home
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon

September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...

Home September 18, 2017
Home
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.
Feature | Cath Lab
VIVA 2017 Late-breaking Clinical Trial Presentations

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...

Home September 14, 2017
Home
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)
Philips Showcases Integrated Vascular Solutions at VIVA 2017

September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...

Home September 13, 2017
Home
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages

September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...

Home September 13, 2017
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now